Skip to content

Oscar Health OSCR Gain (Loss) on Sale of Investments

Gain (Loss) on Sale of Investments at other companies

IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Cash & equivalents$4.8B+114%
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$8.56B+4.0%
Enterprise value$4.16B-174%
P/S0.6×-0.2×

Profitability

See full
Operating margin0.1%
Net margin-0.3%
FCF margin-8.2%

Returns & leverage

See full
Return on equity-2.6%
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfInvestments.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's gain (loss) on sale of investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oscar Health's gain (loss) on sale of investments?
Oscar Health (OSCR) reported gain (loss) on sale of investments of $4K in Q1 2026.
How has Oscar Health's gain (loss) on sale of investments changed year-over-year?
Oscar Health's gain (loss) on sale of investments decreased by 96.6% year-over-year, from $119K to $4K.
What is the long-term trend for Oscar Health's gain (loss) on sale of investments?
Over 2 years (2022 to 2025), Oscar Health's gain (loss) on sale of investments has grown at a -0.3% compound annual growth rate (CAGR), from -$1.35M to $1.34M.